Development of Amorphous Solid Dispersions of Cannabidiol: Influence of the Carrier, the Hot-Melt Extrusion Parameters and the Use of a Crystallization Inhibitor

[1]  J. Pogliano,et al.  The antimicrobial potential of cannabidiol , 2021, Communications Biology.

[2]  B. Evrard,et al.  Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers. , 2020, International journal of pharmaceutics.

[3]  S. O'Sullivan,et al.  Towards Better Delivery of Cannabidiol (CBD) , 2020, Pharmaceuticals.

[4]  David S. Jones,et al.  The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platform. , 2020, International journal of pharmaceutics.

[5]  E. Perucca,et al.  Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications , 2020, CNS Drugs.

[6]  M. Repka,et al.  Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties. , 2020, Carbohydrate polymers.

[7]  Can Wei,et al.  Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release. , 2020, Journal of pharmaceutical sciences.

[8]  P. Dell'orco,et al.  Predicting the Solubility Enhancement of Amorphous Drugs and Related Phenomena Using Basic Thermodynamic Principles and Semi-Empirical Kinetic Models. , 2019, International journal of pharmaceutics.

[9]  P. Amin,et al.  Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology , 2018, Drug Delivery and Translational Research.

[10]  S. O'Sullivan,et al.  A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans , 2018, Front. Pharmacol..

[11]  C. Strachan,et al.  Understanding Dissolution and Crystallization with Imaging: A Surface Point of View , 2018, Molecular pharmaceutics.

[12]  Jamie Corroon,et al.  A Cross-Sectional Study of Cannabidiol Users , 2018, Cannabis and cannabinoid research.

[13]  E. Mazzon,et al.  Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. , 2017, Multiple sclerosis and related disorders.

[14]  R. Suryanarayanan,et al.  Rapid Assessment of the Physical Stability of Amorphous Solid Dispersions , 2017 .

[15]  A. Frère,et al.  Bioavailability enhancement of itraconazole‐based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  C. Jérôme,et al.  Hot‐melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Pierre Lebrun,et al.  Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination. , 2016, International journal of pharmaceutics.

[18]  Dhara D. Bavishi,et al.  Spring and parachute: How cocrystals enhance solubility , 2016 .

[19]  Dinesh Kumar,et al.  Evaluation of the inhibitory potential of HPMC, PVP and HPC polymers on nucleation and crystal growth , 2016 .

[20]  Abhishek Singh,et al.  Spray drying formulation of amorphous solid dispersions. , 2016, Advanced drug delivery reviews.

[21]  Mayur S. Dudhedia,et al.  Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale. , 2016 .

[22]  V. Nekkanti,et al.  Insoluble drug delivery strategies: review of recent advances and business prospects , 2015, Acta pharmaceutica Sinica. B.

[23]  H. Park,et al.  Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  R. Suryanarayanan,et al.  Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions. , 2015, Molecular pharmaceutics.

[25]  H. Mo,et al.  Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation. , 2015, Journal of pharmaceutical sciences.

[26]  Huixia Lv,et al.  Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin , 2015, Pharmaceutical development and technology.

[27]  B. Evrard,et al.  A review of pharmaceutical extrusion: critical process parameters and scaling-up. , 2015, International journal of pharmaceutics.

[28]  K. Higashi,et al.  The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement. , 2014, International journal of pharmaceutics.

[29]  Jean Paul Remon,et al.  Hot‐melt co‐extrusion: requirements, challenges and opportunities for pharmaceutical applications , 2014, The Journal of pharmacy and pharmacology.

[30]  A. D. da Silva,et al.  Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants , 2013, Molecules.

[31]  J. Crippa,et al.  Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  G. Mooter,et al.  The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. , 2012, Drug discovery today. Technologies.

[33]  Ping I. Lee,et al.  Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  David S Jones,et al.  An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations. , 2011, Molecular pharmaceutics.

[35]  Susanna Abrahmsén-Alami,et al.  The influence of crystallization inhibition of HPMC and HPMCAS on model substance dissolution and release in swellable matrix tablets. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  Feng Qian,et al.  Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. , 2010, Journal of pharmaceutical sciences.

[37]  Dave A. Miller,et al.  Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  Peng Wang,et al.  Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. , 2010, International journal of pharmaceutics.

[39]  Lynne S. Taylor,et al.  Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution , 2010, Pharmaceutical Research.

[40]  G. Esposito,et al.  Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders , 2009, Phytotherapy research : PTR.

[41]  J Dressman,et al.  Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products. , 2009, Journal of pharmaceutical sciences.

[42]  Yusuke Shibata,et al.  The preparation of a solid dispersion powder of indomethacin with crospovidone using a twin-screw extruder or kneader. , 2009, International journal of pharmaceutics.

[43]  Lynne S Taylor,et al.  Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  L. Augsburger,et al.  Increasing the Dissolution Rate of a Low-Solubility Drug Through a Crystalline-Amorphous Transition: A Case Study with Indomethicin , 2008, Drug development and industrial pharmacy.

[45]  Lynne S. Taylor,et al.  Ability of Different Polymers to Inhibit the Crystallization of Amorphous Felodipine in the Presence of Moisture , 2008, Pharmaceutical Research.

[46]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[47]  K. Amighi,et al.  Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. , 2005, International journal of pharmaceutics.

[48]  K. Mahadik,et al.  Spray-Dried Amorphous Solid Dispersions of Simvastatin, a Low Tg Drug: In Vitro and in Vivo Evaluations , 2005, Pharmaceutical Research.

[49]  A. Oomen,et al.  Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[50]  S. Rawat,et al.  Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes , 2004 .

[51]  D. Parolaro,et al.  Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[52]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[53]  Bruno C. Hancock,et al.  Disordered drug delivery: destiny, dynamics and the Deborah number , 2002, The Journal of pharmacy and pharmacology.

[54]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.